Finn Partners today unveiled a dedicated health practice called Finn Partners Health, guided by 20-year veteran Miriam Weber Miller.
She guided the launches of BlissHealth and FischerHealth Life Sciences, which was acquired by Porter Novelli, and had key posts at Chandler Chicco’s Biosector 2 and Noonan Russo.
Miller has counseled Amgen, Atrix Labs, Bayer Pharmaceuticals, Humana Novo Nordisk, Portola Pharmaceuticals, Regeneron Pharmaceuticals and Watson Pharmaceuticals.
Peter Finn says FPH begins life with $2M in annual fees. Key health clients are American Assn. American Kidney Fund, Barlow Respiratory Hospital, Los Angeles County Department of Health and Pelican Biopharma.
The new group “is a strategic step forward for Finn Partners, as we continue to expand our geographic and marketplace leadership,” according to Finn’s statement.
With the senior partner/FPH director title, New York-based Miller reports to Alicia Young, managing partner of the Ruder Finn Group spin-off.